What's happening
Summary being written. Track this bill to get it by email.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Sponsors
No co-sponsors yet.
History
- Adopted
- Reported to calendar for consideration
- Referred to finance
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
Senate Resolution No. 612 BY: Senator TEDISCO MEMORIALIZING Governor Kathy Hochul to proclaim May 2023, as Neurofibromatosis Month in the State of New York WHEREAS, It is the custom of this Legislative Body to recognize official months that are set aside to… Show allHide
Senate Resolution No. 612 BY: Senator TEDISCO MEMORIALIZING Governor Kathy Hochul to proclaim May 2023, as Neurofibromatosis Month in the State of New York WHEREAS, It is the custom of this Legislative Body to recognize official months that are set aside to increase awareness of serious illnesses that affect the lives of citizens of New York State; and WHEREAS, This Legislative Body is justly proud to memorialize Governor Kathy Hochul to proclaim May 2023, as Neurofibromatosis Month in the State of New York, in conjunction with the observance of National Neurofibromatosis Month; and WHEREAS, Neurofibromatosis (NF), a debilitating tumor disorder, affects more than 130,000 Americans; and WHEREAS, Neurofibromatosis Northeast has worked for over 30 years on its mission to find a cure for NF; and WHEREAS, With a mission to finding a treatment and cure for NF, Neurofibromatosis Northeast promotes research, creates awareness and supports those who are affected by NF; and WHEREAS, Growing awareness of NF has resulted in increased investment in research through private charities such as NF Northeast and the NF Research Program in the Department of Defense which has resulted in new clinical trials involving application of drugs which have been shown to reduce malignant tumors in cancer; and WHEREAS, In 2019, the FDA approved the use of Koselugo (selumetinib) for treatment of NF1, and promising science using combination therapy, gene therapy and bacterial therapy has led to new clinical trials offering hope for families dealing with the uncertainties of NF; and WHEREAS, Increased awareness of NF will help initiate critical research; NF patients and their families are determined to make Neurofibromatosis a household word; and WHEREAS, It is imperative that there be greater awareness of this serious health condition, and more must be done to increase activity at the local, State and National levels; now, therefore, be it RESOLVED, That this Legislative Body pause in its deliberations to memorialize Governor Kathy Hochul to proclaim May 2023, as Neurofibromatosis Month in the State of New York; and be it further RESOLVED, That a copy of this Resolution, suitably engrossed, be transmitted to The Honorable Kathy Hochul, Governor of the State of New York.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.